NCT05401149View on ClinicalTrials.gov

Alteplase Treatment in Elderly Acute Ischaemic Stroke (AIS) Patients

CompletedOBSERVATIONAL
Enrollment

3,058

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

December 14, 2022

Study Completion Date

December 14, 2022

Conditions
Stroke
Interventions
DRUG

rt-PA

Recombinant Tissue Plasminogen Activator

Trial Locations (1)

200040

Boehringer Ingelheim (China) Investment Co., ltd., Shanghai

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05401149 - Alteplase Treatment in Elderly Acute Ischaemic Stroke (AIS) Patients | Biotech Hunter | Biotech Hunter